SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: celeryroot.com who wrote (737)12/18/1999 12:20:00 PM
From: John McCarthy  Read Replies (1) of 1494
 
Library for NTII Lurkers ...........

The *stuff* below will hopefully quickly introduce you to
this company and **one** of its drugs -- MEMANTINE.

(1) What NTII does ........

1)diabetic neuropathy
2)brain cancer
3)AIDS dementia syndrome.
Source:
edgar-online.com

(2) How much CASH is left ..........

The Company believes that its available cash and
cash equivalents of $547,000 as of September 30, 1999, combined with the net proceeds from the private placement subsequent to the quarter ending, are adequate to fund its operations through this fiscal year ending June 30, 2000.
Source:
edgar-online.com

(3) Large shareholders

(a) Arthur Rock
(b) One Maritime Plaza, #1220 San Francisco, CA 94111

1,664,997 shares of Common Stock or 11.8%

Consists of:
(a)749,926 shares of Common Stock
(b)400,000 shares issuable upon exercise of Common Stock purchase warrants
(c)500,000 of Common Stock issuable upon the conversion of Series A Preferred Stock and
(d)15,071 shares of Common Stock issuable upon exercise of stock
options.
Source:
edgar-online.com

MEMANTINE:

Some stuff on the Internet about one of NTII drugs.

PLEASE NOTE:The stuff below is a 'broad sweep' and includes indications that NTII is both INVOLVED and *** NOT INVOLVED *** in.

I have not read much of this - YET.
It is organized (for the most part) by indication.

AIDS
gopher.nimh.nih.gov
ww2.aegis.com
pano.com
never.ucsf.edu:8000/tsearch/trials/trial31543160.html
hnrc.ucsd.edu
winter.sfn.org

GLAUCOMA
library.northernlight.com
{Caution:Fires JavaScript - have lots of memory)
cuth.cataegu.ac.kr

NEUROPATHIC PAIN
pharminfo.com
wcbrbrain.org
prnewswire.com

ALS
goulburn.net.au

ETHANOL in RATS:
athene.hbz-nrw.de

MICE and MORPHINE:
if-pan.krakow.pl

COCAINE:
It does **NOT** help
griffin.vcu.edu

ALZHEIMERS:
<<Neurobiological Technologies, Inc. (Richmond, CA) has announced publication of positive results of Phase III human clinical trial of Memantine in Europe sponsored by its collaborator Merz GmbH
& Co. (Frankfurt, Germany). The data are published in the March issue of the International Journal of Geriatric Psychiatry. >>
the-infoshop.com
medimedia.com.hk
healthgate.co.uk
web2.po.com

SEVERE DEMENTIA:
psychiatry.ox.ac.uk
f9.parsimony.net

DIABETIC PERIPHERAL NEUROPATHY:
nfb.org
centerwatch.com

A MARKET ANALYSIS ABOUT PAIN - COSTS $4000
newmedinc.com

ION CHANNEL BLOCKERS:
tocris.com
tocris.com

PARKINSON:
wpda.org

regards,
John McCarthy

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext